T. Gunawardena

619 total citations
15 papers, 382 citations indexed

About

T. Gunawardena is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Physiology. According to data from OpenAlex, T. Gunawardena has authored 15 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 4 papers in Genetics and 2 papers in Physiology. Recurrent topics in T. Gunawardena's work include Cystic Fibrosis Research Advances (11 papers), Neonatal Respiratory Health Research (7 papers) and Inhalation and Respiratory Drug Delivery (3 papers). T. Gunawardena is often cited by papers focused on Cystic Fibrosis Research Advances (11 papers), Neonatal Respiratory Health Research (7 papers) and Inhalation and Respiratory Drug Delivery (3 papers). T. Gunawardena collaborates with scholars based in Canada, Italy and United States. T. Gunawardena's co-authors include Mohammad Tariqur Rahman, Noor Hayaty Abu Kasim, Basri Johan Jeet Abdullah, Theo J. Moraes, Christine E. Bear, Onofrio Laselva, Claire Bartlett, Hong Ouyang, Tanja Gonska and Paul D. W. Eckford and has published in prestigious journals such as PLoS ONE, European Respiratory Journal and Cells.

In The Last Decade

T. Gunawardena

13 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Gunawardena Canada 9 238 97 70 40 30 15 382
Yoshiko Hayashi Japan 11 35 0.1× 49 0.5× 103 1.5× 52 1.3× 37 1.2× 31 376
Kenta Uchibe Japan 10 98 0.4× 35 0.4× 213 3.0× 75 1.9× 26 0.9× 19 521
Collin T. Stabler United States 9 151 0.6× 47 0.5× 133 1.9× 202 5.0× 22 0.7× 12 424
Robert A. Brenes United States 8 64 0.3× 38 0.4× 75 1.1× 190 4.8× 14 0.5× 16 332
Erol Rüştü Bozkurt Türkiye 12 101 0.4× 31 0.3× 29 0.4× 186 4.7× 25 0.8× 31 324
Dimitrios Hatzis United States 7 81 0.3× 35 0.4× 185 2.6× 85 2.1× 11 0.4× 7 416
María Rosa Arnau Spain 13 87 0.4× 13 0.1× 147 2.1× 78 1.9× 22 0.7× 18 403
Lindsey Ott United States 8 85 0.4× 73 0.8× 55 0.8× 142 3.5× 9 0.3× 10 282

Countries citing papers authored by T. Gunawardena

Since Specialization
Citations

This map shows the geographic impact of T. Gunawardena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Gunawardena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Gunawardena more than expected).

Fields of papers citing papers by T. Gunawardena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Gunawardena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Gunawardena. The network helps show where T. Gunawardena may publish in the future.

Co-authorship network of co-authors of T. Gunawardena

This figure shows the co-authorship network connecting the top 25 collaborators of T. Gunawardena. A scholar is included among the top collaborators of T. Gunawardena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Gunawardena. T. Gunawardena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Mittal, Kirti, Wenming Duan, T. Gunawardena, et al.. (2024). Impact of Acute E-cigarette Aerosol Exposure on Human Airway Epithelial Cells. A4425–A4425. 1 indexed citations
2.
3.
Ip, Wan, Claire Bartlett, Julie Avolio, et al.. (2023). Validating organoid-derived human intestinal monolayers for personalized therapy in cystic fibrosis. Life Science Alliance. 6(6). e202201857–e202201857. 8 indexed citations
4.
Gunawardena, T., Zoltán Bozóky, Claire Bartlett, et al.. (2023). Correlation of Electrophysiological and Fluorescence-Based Measurements of Modulator Efficacy in Nasal Epithelial Cultures Derived from People with Cystic Fibrosis. Cells. 12(8). 1174–1174. 4 indexed citations
5.
Ratjen, Félix, Sanja Stanojevic, T. Gunawardena, et al.. (2023). Correlations between in-vitro and clinical drug response to CFTR modulators. PA3375–PA3375. 1 indexed citations
6.
Gunawardena, T., et al.. (2023). Primary Human Nasal Epithelial Cell Culture. Methods in molecular biology. 2725. 213–223.
7.
Terlizzi, Vito, et al.. (2022). Modulator Therapy in Cystic Fibrosis Patients with cis Variants in F508del Complex Allele: A Short-Term Observational Case Series. Journal of Personalized Medicine. 12(9). 1421–1421. 10 indexed citations
8.
Wellhauser, Leigh, Onofrio Laselva, Zoltán Bozóky, et al.. (2021). A new platform for high-throughput therapy testing on iPSC-derived lung progenitor cells from cystic fibrosis patients. Stem Cell Reports. 16(11). 2825–2837. 21 indexed citations
9.
Cao, Huibi, Hong Ouyang, Onofrio Laselva, et al.. (2020). A helper-dependent adenoviral vector rescues CFTR to wild-type functional levels in cystic fibrosis epithelial cells harbouring class I mutations. European Respiratory Journal. 56(5). 2000205–2000205. 23 indexed citations
10.
Laselva, Onofrio, Claire Bartlett, Hong Ouyang, et al.. (2020). Emerging preclinical modulators developed for F508del-CFTR have the potential to be effective for ORKAMBI resistant processing mutants. Journal of Cystic Fibrosis. 20(1). 106–119. 32 indexed citations
11.
Laselva, Onofrio, Claire Bartlett, T. Gunawardena, et al.. (2020). Rescue of multiple class II CFTR mutations by elexacaftor+tezacaftor+ivacaftor mediated in part by the dual activities of elexacaftor as both corrector and potentiator. European Respiratory Journal. 57(6). 2002774–2002774. 109 indexed citations
12.
Laselva, Onofrio, Jacqueline McCormack, Claire Bartlett, et al.. (2020). Preclinical Studies of a Rare CF-Causing Mutation in the Second Nucleotide Binding Domain (c.3700A>G) Show Robust Functional Rescue in Primary Nasal Cultures by Novel CFTR Modulators. Journal of Personalized Medicine. 10(4). 209–209. 23 indexed citations
13.
Laselva, Onofrio, Theo J. Moraes, Gengming He, et al.. (2020). The CFTR Mutation c.3453G > C (D1152H) Confers an Anion Selectivity Defect in Primary Airway Tissue that Can be Rescued by Ivacaftor. Journal of Personalized Medicine. 10(2). 40–40. 24 indexed citations
14.
Gunawardena, T., et al.. (2019). Dental derived stem cell conditioned media for hair growth stimulation. PLoS ONE. 14(5). e0216003–e0216003. 16 indexed citations
15.
Gunawardena, T., Mohammad Tariqur Rahman, Basri Johan Jeet Abdullah, & Noor Hayaty Abu Kasim. (2019). Conditioned media derived from mesenchymal stem cell cultures: The next generation for regenerative medicine. Journal of Tissue Engineering and Regenerative Medicine. 13(4). 569–586. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026